Alan K. Davis

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Effects of Psychedelic Use on Racial Trauma Symptoms and Ethnic Identity among Asians in North America”.

Effects of Psychedelic Use on Racial Trauma Symptoms and Ethnic Identity among Asians in North America

Journal of Psychoactive Drugs(2022)10.1080/02791072.2022.2025960

N/A

0.963DataRank · unranked

34 citations

Alan K. Davis, Yitong Xin, Monnica T. Williams, Terence H. W. Ching

People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences

Drugs Education Prevention and Policy(2020)10.1080/09687637.2020.1854688

N/A

0.695DataRank · unranked

102 citations

Alan K. Davis, Yitong Xin, Nathan D. Sepeda, Pamela Colón Grigas, Sinead M. Sinnott +2 more

Implementing traumatic brain injury screening in behavioral healthcare: protocol for a prospective mixed methods study

Implementation Science Communications(2022)10.1186/s43058-022-00261-x

N/A

0DataRank · unranked

11 citations

Alicia C. Bunger, Jennifer Bogner, Alan K. Davis, John D. Corrigan, Kathryn A. Hyzak

Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis

Psychiatry Research(2023)10.1016/j.psychres.2023.115349

N/A

0DataRank · unranked

24 citations

Per Carlbring, Robin Carhart‐Harris, Alan K. Davis, David Nutt, Roland R. Griffiths +3 more

Implementing traumatic brain injury screening in behavioral health treatment settings: results of an explanatory sequential mixed-methods investigation

Implementation Science(2023)10.1186/s13012-023-01289-w

N/A

0DataRank · unranked

11 citations

Alicia C. Bunger, Jennifer Bogner, Alan K. Davis, John D. Corrigan, Kathryn A. Hyzak

Investigating the associations of acute psychedelic experiences and changes in racial trauma symptoms, psychological flexibility, and substance use among People with Racial and Ethnic Minoritized Identities in the United States and Canada

Journal of Substance Use and Addiction Treatment(2023)10.1016/j.josat.2023.209035

N/A

0DataRank · unranked

10 citations

Joel Lopez, Pamela A. Colón Grigas, Maria C. Crouch, Alan K. Davis, Monnica T. Williams +1 more

An international Delphi consensus for reporting of setting in psychedelic clinical trials

Nature Medicine(2025)10.1038/s41591-025-03685-9

N/A

0DataRank · unranked

27 citations

Kyle T. Greenway, Leor Roseman, The ReSPCT Experts, Jacob S. Aday, Gabrielle Agin-Liebes +77 more

Applying Lessons From Cannabis to the Psychedelic Highway

JAMA Health Forum(2022)10.1001/jamahealthforum.2022.1618

N/A

0DataRank · unranked

20 citations

Alan K. Davis, Jenna McAfee, Kevin F. Boehnke